LL37 Peptide – Research Overview
LL37 peptide is a well-characterized human antimicrobial peptide widely studied in immunology, microbiology, and host defense research. Importantly, it is the only known member of the human cathelicidin family. As a result, researchers frequently use this peptide in experimental models focused on innate immune signaling and microbial interaction mechanisms.
At the same time, this product is supplied strictly for laboratory research purposes and is not intended for human or veterinary use.
What Is This Antimicrobial Peptide?
This peptide originates from the C-terminal region of the human cathelicidin precursor protein hCAP-18. For this reason, researchers study this compound because of its cationic properties and its interaction with microbial membranes and immune-related signaling pathways.
Moreover, its defined amino acid sequence supports reproducible application in controlled experimental systems. Therefore, it is suitable for comparative and mechanistic research designs.
Research Applications of LL37 Peptide
In laboratory and preclinical research environments, LL37 peptide is commonly applied in multiple study areas. For example, researchers may include it in:
-
Antimicrobial activity assessment
-
Innate immune response modeling
-
Host–pathogen interaction analysis
-
Inflammatory signaling pathway research
-
Cell membrane interaction studies
As a result, this peptide often serves as a reference compound in immune-focused experimental workflows. Consequently, it is widely recognized across immunology-related research disciplines.
Biological Characteristics and Mechanistic Focus
This antimicrobial peptide displays several properties that support laboratory research. In particular, its positive charge facilitates membrane interaction under experimental conditions. In addition, its amphipathic helical structure forms reliably under physiological environments.
Therefore, researchers often select this compound to explore innate immune mechanisms in vitro. Overall, these characteristics contribute to its consistent performance in controlled laboratory models.
Product Features for Research Use
This peptide is provided to meet laboratory and analytical research requirements. Specifically, it is supplied as a research-grade synthetic peptide in lyophilized form. Moreover, batch control supports experimental consistency.
As a result, it is appropriate for research institutions, laboratories, and R&D organizations that require reproducible peptide materials.
Regulatory and Research Use Disclaimer
LL37 peptide is supplied for research and laboratory use only. Accordingly, it is not approved for human or animal consumption, clinical application, or therapeutic use.
